Observational study on BPH treatment in Greek men

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on Greek male patients suffering from benign prostatic hyperplasia (BPH) who have moderate to severe symptoms and are not adequately responding to monotherapy. The study aims to assess disease control and quality of life under fixed-dose combination treatment with Solifenacin and Tamsulosin. It will involve multiple urology departments across Greece, collecting data on patient experiences and outcomes related to their BPH treatment. The study will help to better understand the effectiveness of this combination therapy in real-world settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male adult patient with moderate to severe symptoms of BPH receiving monotherapy and not responding adequately.
* Male adult patient with BPH who has fully understood the study procedures and signed an informed consent form.

Exclusion Criteria:

\-

Where it's running

• Department of Urology, Venizelio General Ηospital
  Heraklion, Greece, Greece Recruiting
• Department of Urology, General Hospital of Messinia
  Kalamata, Greece, Greece Recruiting
• Department of Urology, General Hospital of Larissa
  Larissa, Greece, Greece Recruiting
• Department of Urology, University Hospital of Rion
  Pátrai, Greece, Greece Recruiting
• First Department of Urology, School of Medicine, Aristotle University of Thessaloniki
  Thessaloniki, Greece, Greece Recruiting
• Second Department of Urology, Sismanoglio Hospital, Athens, Greece.
  Athens, Greece, Greece Not yet recruiting

Study contacts

• Study coordinator: Polyanthi Papanastasiou
• Email: p.papanastasiou@elpen.gr
• Phone: +302111865777

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sonablate HIFU Registry for Prostate Cancer and BPH

  This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.

  Recruiting Sonablate · Indianapolis, Indiana · NCT07757490

• Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate

  This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07722884

• MRI-DTI look at the urethral sphincter ring and prostate base shape

  This imaging study tests how the male urethral internal sphincter ring appears on MRI-DTI and how it relates to prostate base morphology in men undergoing clinically indicated MRI.

  Recruiting Jiangsu Taizhou People's Hospital · Taizhou, Jiangsu · NCT07694752

• Tamsulosin With or Without Tadalafil for a Trial Without Catheter After Acute Urinary Retention

  This study tests whether adding tadalafil to tamsulosin helps men with a first episode of acute urinary retention due to enlarged prostate pass urine without needing a catheter.

  Recruiting Phase 4 Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07654413

• Tamsulosin dose change or switch to silodosin before catheter removal in men with BPH-related acute urinary retention

  This trial tests whether continuing tamsulosin, increasing its dose, or switching to silodosin helps men with BPH-related acute urinary retention go without a catheter after seven days.

  Recruiting Phase 4 Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07650968

• Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia

  This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.

  Recruiting Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07648888

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.